Beam Therapeutics Inc. (BEAM) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Beam Therapeutics Inc.

NASDAQ: BEAM · Real-Time Price · USD
22.97
-0.12 (-0.52%)
At close: Sep 26, 2025, 3:59 PM
23.10
0.57%
After-hours: Sep 26, 2025, 07:54 PM EDT

Beam Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
281.97M 435.89M 232.77M 965.65M
Short-Term Investments
568.77M 753.98M 845.37M 405.65M
Long-Term Investments
n/a n/a 12.75M 12.75M
Other Long-Term Assets
9.4M 10.87M 1.93M 309.08M
Receivables
n/a n/a n/a 300M
Inventory
n/a n/a n/a -607.36M
Other Current Assets
27.41M 21.17M 14.76M n/a
Total Current Assets
878.15M 1.21B 1.09B 965.65M
Property-Plant & Equipment
216.28M 237.81M 234.13M 186.98M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
225.68M 248.67M 248.82M 508.81M
Total Assets
1.1B 1.46B 1.34B 1.47B
Account Payables
3.87M 1.62M 9.03M 7.47M
Deferred Revenue
108.86M 68.71M 135.97M 86.27M
Short-Term Debt
n/a n/a 1.85M 2.29M
Other Current Liabilities
37.78M 100.69M 49.09M 100.49M
Total Current Liabilities
182.07M 205.56M 223.59M 213.44M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
7.04M 3.02M 13.84M 37.17M
Total Long-Term Liabilities
188.21M 272.82M 384.64M 434.28M
Total Liabilities
370.28M 478.38M 608.24M 647.72M
Total Debt
161.43M 172.69M 179M 142.35M
Book Value
733.54M 981.33M 733.47M 826.74M
Book Value Per Share
8.91 12.72 10.48 12.87
Common Stock
836K 816K 712K 684K
Retained Earnings
-1.57B -1.19B -1.06B -768.27M
Comprehensive Income
679K 604K -2.43M -50K
Shareholders Equity
733.54M 981.33M 733.47M 826.74M
Total Investments
568.77M 753.98M 845.37M 405.65M